BE647556A - - Google Patents

Info

Publication number
BE647556A
BE647556A BE647556A BE647556A BE647556A BE 647556 A BE647556 A BE 647556A BE 647556 A BE647556 A BE 647556A BE 647556 A BE647556 A BE 647556A BE 647556 A BE647556 A BE 647556A
Authority
BE
Belgium
Prior art keywords
acid
tome
desc
page number
clms page
Prior art date
Application number
BE647556A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BE647556A priority Critical patent/BE647556A/fr
Publication of BE647556A publication Critical patent/BE647556A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE647556A 1964-05-06 1964-05-06 BE647556A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BE647556A BE647556A (ja) 1964-05-06 1964-05-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE647556A BE647556A (ja) 1964-05-06 1964-05-06

Publications (1)

Publication Number Publication Date
BE647556A true BE647556A (ja) 1964-08-31

Family

ID=3846496

Family Applications (1)

Application Number Title Priority Date Filing Date
BE647556A BE647556A (ja) 1964-05-06 1964-05-06

Country Status (1)

Country Link
BE (1) BE647556A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007597A1 (de) * 1978-07-20 1980-02-06 Stiftung Deutsches Krebsforschungszentrum N-Niedrigalkylglycinamide und Sarkosinanhydrid sowie in Kombination mit bekannten tumorhemmenden Verbindungen vorliegendes Sarkosin zur Anwendung bei der Heilung von Tumoren sowie dieselben enthaltendes Mittel und Verfahren zu dessen Herstellung
FR2531950A1 (fr) * 1982-08-20 1984-02-24 Midit Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007597A1 (de) * 1978-07-20 1980-02-06 Stiftung Deutsches Krebsforschungszentrum N-Niedrigalkylglycinamide und Sarkosinanhydrid sowie in Kombination mit bekannten tumorhemmenden Verbindungen vorliegendes Sarkosin zur Anwendung bei der Heilung von Tumoren sowie dieselben enthaltendes Mittel und Verfahren zu dessen Herstellung
FR2531950A1 (fr) * 1982-08-20 1984-02-24 Midit Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant

Similar Documents

Publication Publication Date Title
UA70277C2 (en) Formulation of vasodilator agent for modulating seformulation of vasodilator agent for modulating sexual response on demand (variants) xual response on demand (variants)
KR20000010847A (ko) 단순 포진 바이러스 및 다른 감염성 질병의 치료를 위한 항균성조성물
JP2006527734A (ja) 局所投与のための麻酔用組成物
BE647556A (ja)
JP5558573B2 (ja) 糖尿病性足潰瘍用の局所用製剤
US4985257A (en) Hemorrhoidal treatment and composition
EP1647282A1 (en) Topical anti-inflammatory aqueous gel containing menthol, thymol and eucalyptol, process for their preparation and use of thereof
Sutherland et al. Local inactivation of funnel‐web spider (Atrax robustus) venom by first‐aid measures: potentially lifesaving part of treatment
PT683670E (pt) Composicoes cicatrizadoras de feridas que contem iodo e um acucar nao redutor
JPH01299219A (ja) メンフェゴールからなるヒト免疫不全ウイルス感染予防剤
RU2367416C1 (ru) Средство для лечения животных при послеродовом эндометрите
US8236814B2 (en) Composition and method for treatment of warts
US2095571A (en) Antiseptic
RU2181282C2 (ru) Препарат для профилактики и лечения эндометритов у коров
EP1516631A1 (fr) Onguent, pour le corps à effets décongestionnant et faire disparaitre progressivement les douleurs musculaires, foulures, entorses, déboitements, courbatures et apaiser les douleurs articulaires et rhumatismales
JPS6229521A (ja) 浅在性真菌症の治療剤
JP4105732B2 (ja) メニエール病治療薬
JPH02193929A (ja) 糖尿病治療剤
RU2580280C2 (ru) Композиция для местного применения для снижения или снятия болевого синдрома
JP2001048783A (ja) 経皮吸収型頻尿・尿失禁治療剤
TWI252103B (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and Behcet&#39;s syndrome
Dahiya et al. Traditional medicine for cervico-vaginal prolapse management in a buffalo
US20210015965A1 (en) Means and methods for wound healing
Baker Open-joint
AKTICLE External Use of Salicylic Acid.